How cities and urban transport systems are developed, is crucial for important societal goals to be reached: zero-growth in road traffic in urban areas, more climate-friendly, attractive and liveable cities, with vibrant and strong city centres, and a more universally designed society. How can technology help and prevent us from achieving these goals?

  • Anne Beate Hovind, Bjørvika Utvikling
  • Bernt Reitan Jensen, Ruter
  • Olav Madland, Applied Autonomy AS
  • Joel Jarvinen, Uber
  • Brage Baklien, Ministry of Transport and Communications

Moderator: Gunnar Lindberg, TØI



by The Young Academy of Norway

Translating scientific knowledge within life science into economic and social benefit is a priority for governments and research funding agencies. Norway has a growing ecosystem within the biotechnology and health-related domain with recent successes causing optimism and enthusiasm among investors. Since most innovations in life science come from environments with focus on groundbreaking basic research, academia plays an important role in translating innovative ideas and exciting research results into commercialization. However, most of the innovations come from a limited number of research groups with a culture for innovation. How can we increase the interest so that more research groups participate? Licensing is often the preferred commercialization path, rather than starting a company. Why is it so? Which steps can be taken to change this? What can be done to build robust research environments with an eye on innovation? Which incentives can be used to make it more attractive for researchers to explore their innovative ideas, and then to start a company? We welcome you to a session where the potential of the University of Oslo as a powerhouse for innovation-driven research and commercialization will be debated.

  • Per Morten Sandset, Vice-Rector for Research and Innovation at UiO
  • Karoline Western Schjetne, Vice President Scientific Affairs, Vacciboby AS
  • Ketil F. Widerberg, General Manager at Oslo Cancer Cluster
  • Esben A. Nilssen, Managing Partner, Sharelab
  • Ole Kristian Hjelstuen, Chief Executive Officer, Inven2



by The The Life Science Cluster

If you ask people what bioeconomy is all about, very few can answer. That´s a pity, because in our ignorance we take the risk of missing enormous opportunities!

The goal of the bioeconomy is to provide the world with better food, improved health, renewable energy and sustainable growth. All this can be achieved if we process biological resources in a more sustainable, efficient and integrated manner.

Norway should be very well positioned to take a lead role in the transition to a green and sustainable economy.  We have knowledge, capital and biological resources from aquaculture and fisheries, forestry and agriculture.

How tremendous are the opportunities deriving from the bioecomony? And how do we get started? Learn all about the unutilized possibilities in the bioeconomy when representatives from the bio-industry meet in a panel discussion at the Cutting Edge-festival on the 25th of September.

  • Marius Holm, General Manager, Zero Norway.
  • Monica Larsen, Manager of Research and Development, Legemiddelindustrien
  • Odd Magne Rødseth, Group Director, Aquaculture, EW Group GmbH
  • Ellen Cathrine Rasmussen, VP for sustainability programs and global projects, Business Unit Food Chain and Global Solutions, YARA
  • Morten Sollerud, CEO, Norilia